113 related articles for article (PubMed ID: 12148540)
21. Immunologic uniqueness of the genital tract: challenge for vaccine development.
Mestecky J; Moldoveanu Z; Russell MW
Am J Reprod Immunol; 2005 May; 53(5):208-14. PubMed ID: 15833098
[TBL] [Abstract][Full Text] [Related]
22. Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract.
Rosenthal KL; Gallichan WS
Semin Immunol; 1997 Oct; 9(5):303-14. PubMed ID: 9327525
[TBL] [Abstract][Full Text] [Related]
23. Combined oral/nasal immunization protects mice from Sendai virus infection.
Nedrud JG; Liang XP; Hague N; Lamm ME
J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
[TBL] [Abstract][Full Text] [Related]
24. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
25. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
[TBL] [Abstract][Full Text] [Related]
26. Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.
Wassen L; Jertborn M
Clin Vaccine Immunol; 2006 Feb; 13(2):202-7. PubMed ID: 16467326
[TBL] [Abstract][Full Text] [Related]
27. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
28. Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model.
Liu Y; Hammer LA; Liu W; Hobbs MM; Zielke RA; Sikora AE; Jerse AE; Egilmez NK; Russell MW
Mucosal Immunol; 2017 Nov; 10(6):1594-1608. PubMed ID: 28272393
[TBL] [Abstract][Full Text] [Related]
29. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
[TBL] [Abstract][Full Text] [Related]
30. B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues. Role of adjuvants and routes of immunization.
Rodríguez A; Troye-Blomberg M; Lindroth K; Ivanyi J; Singh M; Fernández C
Vaccine; 2003 Jan; 21(5-6):458-67. PubMed ID: 12531644
[TBL] [Abstract][Full Text] [Related]
31. CD4⁺ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization.
Marks E; Helgeby A; Andersson JO; Schön K; Lycke NY
Eur J Immunol; 2011 Sep; 41(9):2642-53. PubMed ID: 21681740
[TBL] [Abstract][Full Text] [Related]
32. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
[TBL] [Abstract][Full Text] [Related]
33. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
[TBL] [Abstract][Full Text] [Related]
34. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections.
Hedges SR; Mayo MS; Mestecky J; Hook EW; Russell MW
Infect Immun; 1999 Aug; 67(8):3937-46. PubMed ID: 10417159
[TBL] [Abstract][Full Text] [Related]
35. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
[TBL] [Abstract][Full Text] [Related]
36. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
Klavinskis LS; Barnfield C; Gao L; Parker S
J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393
[TBL] [Abstract][Full Text] [Related]
37. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
[TBL] [Abstract][Full Text] [Related]
38. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
Staats HF; Nichols WG; Palker TJ
J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
[TBL] [Abstract][Full Text] [Related]
39. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
40. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
Wu HY; Russell MW
Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
